Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Calendar


November 4, 2021 - Interim report July-September
November 11, 2021 - Redeye Life Science Day 2021
November 24-25, 2021 - Nordea Virtual Innovation Seminar 2021
November 30, 2021 - ABG Nordic Seminar

Share

Twitter
LinkedIn

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: info@egetis.com